University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO.
Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Am J Kidney Dis. 2018 Jan;71(1):65-74. doi: 10.1053/j.ajkd.2017.07.015. Epub 2017 Nov 20.
Diabetic kidney disease is a major cause of premature mortality in type 2 diabetes mellitus (T2DM). Worsening insulin sensitivity independent of glycemic control may contribute to the development of diabetic kidney disease. We investigated the longitudinal association of insulin sensitivity with hyperfiltration and increased albumin excretion in adolescents with T2DM.
Observational prospective cohort study.
SETTING & PARTICIPANTS: 532 TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) participants aged 12 to 17 years with T2DM duration less than 2 years at baseline. The TODAY Study was a multicenter randomized clinical trial that examined the efficacy of 3 treatment regimens (metformin monotherapy, metformin plus rosiglitazone, or metformin plus an intensive lifestyle intervention program) to achieve durable glycemic control.
Natural log-transformed estimated insulin sensitivity (reciprocal of fasting insulin), hemoglobin A concentration, age, race-ethnicity, treatment group, body mass index, loss of glycemic control, and hypertension.
Hyperfiltration was defined as 99th percentile or higher of estimated glomerular filtration rate (≥140mL/min/1.73m) when referenced to healthy adolescents (NHANES 1999-2002) and albumin-creatinine ratio ≥ 30μg/mg at 3 consecutive annual visits.
Hyperfiltration was observed in 7.0% of participants at baseline and in 13.3% by 5 years, with a cumulative incidence of 5.0% over 5 years. The prevalence of increased albumin excretion was 6% at baseline and 18% by 5 years, with a cumulative incidence of 13.4%. There was an 8% increase in risk for hyperfiltration per 10% lower estimated insulin sensitivity in unadjusted and adjusted models (P=0.01). Increased albumin excretion was associated with hemoglobin A concentration, but not estimated insulin sensitivity.
Longer follow-up is needed to capture the transition from hyperfiltration to rapid glomerular filtration rate decline in youth-onset T2DM.
Lower estimated insulin sensitivity was associated with risk for hyperfiltration over time, whereas increased albumin excretion was associated with hyperglycemia in youth-onset T2DM.
糖尿病肾病是 2 型糖尿病(T2DM)患者过早死亡的主要原因。独立于血糖控制的胰岛素敏感性恶化可能导致糖尿病肾病的发展。我们研究了青少年 T2DM 中胰岛素敏感性与高滤过和白蛋白排泄增加的纵向关联。
观察性前瞻性队列研究。
532 名 TODAY(青少年和青年 2 型糖尿病的治疗选择)参与者,基线时 T2DM 病程不足 2 年,年龄在 12 至 17 岁之间。TODAY 研究是一项多中心随机临床试验,研究了 3 种治疗方案(二甲双胍单药治疗、二甲双胍加罗格列酮治疗或二甲双胍加强化生活方式干预方案)对实现持久血糖控制的疗效。
自然对数转换的估计胰岛素敏感性(空腹胰岛素的倒数)、血红蛋白 A 浓度、年龄、种族、治疗组、体重指数、血糖控制丢失和高血压。
当参考健康青少年(NHANES 1999-2002)时,肾小球滤过率估计值的第 99 百分位数或更高(≥140mL/min/1.73m)定义为高滤过,并且在 3 次连续年度就诊时白蛋白/肌酐比值≥30μg/mg。
基线时有 7.0%的参与者存在高滤过,5 年后有 13.3%的参与者存在高滤过,5 年内累积发生率为 5.0%。基线时白蛋白排泄增加的患病率为 6%,5 年后为 18%,5 年内累积发生率为 13.4%。在未调整和调整模型中,估计胰岛素敏感性每降低 10%,高滤过的风险增加 8%(P=0.01)。白蛋白排泄增加与血红蛋白 A 浓度相关,但与估计的胰岛素敏感性无关。
需要更长的随访时间来捕捉青少年起 2 型糖尿病从高滤过到肾小球滤过率快速下降的转变。
在青少年起 2 型糖尿病中,估计的胰岛素敏感性较低与高滤过的风险随时间增加相关,而白蛋白排泄增加与高血糖相关。